Medical Properties Trust (MPW) 10-Q 11 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	8-May-15
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Trading Symbol	MPW
Entity Registrant Name	MEDICAL PROPERTIES TRUST INC.
Entity Central Index Key	1287865
Current Fiscal Year End Date	-19
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		208,915,766
MPT Operating Partnership, L.P. [Member]
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	FALSE
Document Period End Date	31-Mar-15
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1
Entity Registrant Name	MPT Operating Partnership, L.P.
Entity Central Index Key	1524607
Current Fiscal Year End Date	-19
Entity Filer Category	Non-accelerated Filer

Condensed_Consolidated_Balance

Condensed Consolidated Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Real estate assets
Land, buildings and improvements, and intangible lease assets	$2,287,024	$2,172,775
Mortgage loans	437,591	397,594
Net investment in direct financing leases	453,423	439,516
Gross investment in real estate assets	3,178,038	3,009,885
Accumulated depreciation and amortization	-216,629	-202,627
Net investment in real estate assets	2,961,409	2,807,258
Cash and cash equivalents	33,548	144,541
Interest and rent receivables	40,464	41,137
Straight-line rent receivables	63,590	59,128
Other loans	601,957	573,167
Other assets	122,081	122,105
Total Assets	3,823,049	3,747,336
Liabilities
Debt, net	1,882,319	2,201,654
Accounts payable and accrued expenses	111,187	112,623
Deferred revenue	25,362	27,207
Lease deposits and other obligations to tenants	8,480	23,805
Total liabilities	2,027,348	2,365,289
Equity / Capital
Preferred stock, $0.001 par value. Authorized 10,000 shares; no shares outstanding
Common stock, $0.001 par value. Authorized 250,000 shares; issued and outstanding - 207,731 shares at March 31, 2015, and 172,743 shares at December 31, 2014	207	172
Limited Partners:
Additional paid in capital	2,248,137	1,765,381
Distributions in excess of net income	-371,459	-361,330
Accumulated other comprehensive loss	-80,922	-21,914
Treasury shares, at cost	-262	-262
Total Equity / Capital	1,795,701	1,382,047
Total Liabilities and Equity / Capital	3,823,049	3,747,336
MPT Operating Partnership, L.P. [Member]
Real estate assets
Land, buildings and improvements, and intangible lease assets	2,287,024	2,172,775
Mortgage loans	437,591	397,594
Net investment in direct financing leases	453,423	439,516
Gross investment in real estate assets	3,178,038	3,009,885
Accumulated depreciation and amortization	-216,629	-202,627
Net investment in real estate assets	2,961,409	2,807,258
Cash and cash equivalents	33,548	144,541
Interest and rent receivables	40,464	41,137
Straight-line rent receivables	63,590	59,128
Other loans	601,957	573,167
Other assets	122,081	122,105
Total Assets	3,823,049	3,747,336
Liabilities
Debt, net	1,882,319	2,201,654
Accounts payable and accrued expenses	65,232	74,195
Deferred revenue	25,362	27,207
Lease deposits and other obligations to tenants	8,480	23,805
Payable due to Medical Properties Trust, Inc.	45,565	38,038
Total liabilities	2,026,958	2,364,899
Limited Partners:
Accumulated other comprehensive loss	-80,922	-21,914
Total Equity / Capital	1,796,091	1,382,437
Total Liabilities and Equity / Capital	3,823,049	3,747,336
MPT Operating Partnership, L.P. [Member] | Common Units [Member]
Limited Partners:
Limited Partners Capital	1,858,231	1,390,296
MPT Operating Partnership, L.P. [Member] | General Partner [Member]
Equity / Capital
General Partner - issued and outstanding - 2,072 units at March 31, 2015 and 1,722 units at December 31, 2014	18,782	14,055
MPT Operating Partnership, L.P. [Member] | LTIP Units [Member]
Limited Partners:
Limited Partners Capital	$0	$0

Condensed_Consolidated_Balance1

Condensed Consolidated Balance Sheets (Parenthetical) (USD $)	Mar. 31, 2015	Dec. 31, 2014
Preferred stock, par value	$0.00	$0.00
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares outstanding	0	0
Common stock, par value	$0.00	$0.00
Common stock, shares authorized	250,000,000	250,000,000
Common stock, shares issued	207,731,000	172,743,000
Common stock, shares outstanding	207,731,000	172,743,000
General Partner [Member] | MPT Operating Partnership, L.P. [Member]
General partner, units issued	2,072,000	1,722,000
General partner, units outstanding	2,072,000	1,722,000
LTIP Units [Member] | MPT Operating Partnership, L.P. [Member]
LTIP Units, shares issued	292,000	292,000
LTIP Units, shares outstanding	292,000	292,000
Common Units [Member] | MPT Operating Partnership, L.P. [Member]
Limited Partners, units issued	205,659,000	171,021,000
Limited Partners, units outstanding	205,659,000	171,021,000

Condensed_Consolidated_Stateme

Condensed Consolidated Statements of Net Income (Unaudited) (USD $)	3 Months Ended
In Thousands, except Per Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Revenues
Rent billed	$53,100	$42,957
Straight-line rent	4,728	2,148
Income from direct financing leases	12,555	12,215
Interest and fee income	25,578	15,769
Total revenues	95,961	73,089
Expenses
Real estate depreciation and amortization	14,756	13,690
Impairment charges		20,496
Property-related	351	738
General and administrative	10,905	8,959
Acquisition expenses	6,239	512
Total operating expenses	32,251	44,395
Operating income	63,710	28,694
Other income (expense)
Other income (expense)	-796	-50
Earnings from equity and other interests	103	220
Interest expense	-26,666	-21,612
Income tax benefit (expense)	-375	57
Net other expense	-27,734	-21,385
Income from continuing operations	35,976	7,309
Income (loss) from discontinued operations		-2
Net income	35,976	7,307
Net income attributable to non-controlling interests	-79	-66
Net income attributable to MPT common stockholders	35,897	7,241
Earnings per share / unit - basic
Income from continuing operations attributable to MPT common stockholders	$0.18	$0.04
Income (loss) from discontinued operations attributable to MPT common stockholders	$0	$0
Net income attributable to MPT common stockholders	$0.18	$0.04
Weighted average shares (units) outstanding - basic	202,958	163,973
Earnings per share / unit - diluted
Income from continuing operations attributable to MPT common stockholders	$0.17	$0.04
Income (loss) from discontinued operations attributable to MPT common stockholders	$0	$0
Net income attributable to MPT common stockholders	$0.17	$0.04
Weighted average shares (units) outstanding - diluted	203,615	164,549
Dividends declared per common share / unit	$0.22	$0.21
MPT Operating Partnership, L.P. [Member]
Revenues
Rent billed	53,100	42,957
Straight-line rent	4,728	2,148
Income from direct financing leases	12,555	12,215
Interest and fee income	25,578	15,769
Total revenues	95,961	73,089
Expenses
Real estate depreciation and amortization	14,756	13,690
Impairment charges		20,496
Property-related	351	738
General and administrative	10,905	8,959
Acquisition expenses	6,239	512
Total operating expenses	32,251	44,395
Operating income	63,710	28,694
Other income (expense)
Other income (expense)	-796	-50
Earnings from equity and other interests	103	220
Interest expense	-26,666	-21,612
Income tax benefit (expense)	-375	57
Net other expense	-27,734	-21,385
Income from continuing operations	35,976	7,309
Income (loss) from discontinued operations		-2
Net income	35,976	7,307
Net income attributable to non-controlling interests	-79	-66
Net income attributable to MPT common stockholders	$35,897	$7,241
Earnings per share / unit - basic
Income from continuing operations attributable to MPT common stockholders	$0.18	$0.04
Income (loss) from discontinued operations attributable to MPT common stockholders	$0	$0
Net income attributable to MPT common stockholders	$0.18	$0.04
Weighted average shares (units) outstanding - basic	202,958	163,973
Earnings per share / unit - diluted
Income from continuing operations attributable to MPT common stockholders	$0.17	$0.04
Income (loss) from discontinued operations attributable to MPT common stockholders	$0	$0
Net income attributable to MPT common stockholders	$0.17	$0.04
Weighted average shares (units) outstanding - diluted	203,615	164,549
Dividends declared per common share / unit	$0.22	$0.21

Condensed_Consolidated_Stateme1

Condensed Consolidated Statements of Comprehensive Income (Loss) (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Net income	$35,976	$7,307
Other comprehensive income
Unrealized gain on interest rate swap	585	721
Foreign currency translation loss	-59,593	-28
Total comprehensive income (loss)	-23,032	8,000
Comprehensive income (loss) attributable to non-controlling interests	-79	-66
Comprehensive income (loss) attributable to MPT common stockholders (Operating Partnership partners)	-23,111	7,934
MPT Operating Partnership, L.P. [Member]
Net income	35,976	7,307
Other comprehensive income
Unrealized gain on interest rate swap	585	721
Foreign currency translation loss	-59,593	-28
Total comprehensive income (loss)	-23,032	8,000
Comprehensive income (loss) attributable to non-controlling interests	-79	-66
Comprehensive income (loss) attributable to MPT common stockholders (Operating Partnership partners)	($23,111)	$7,934

Condensed_Consolidated_Stateme2

Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Operating activities
Net income	$35,976	$7,307
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,074	13,972
Direct financing lease interest accretion	-1,604	-1,604
Straight-line rent revenue	-4,728	-3,099
Straight-line rent write-off		950
Impairment charges		20,496
Share (Unit)-based compensation	2,825	2,287
Amortization and write-off of deferred financing costs and debt discount	1,377	1,049
Other adjustments	-1,290	1,239
Changes in
Interest and rent receivables	667	-4,674
Accounts payable and accrued expenses	-6,271	-19,641
Net cash provided by operating activities	42,026	18,282
Investing activities
Cash paid for acquisitions and other related investments	-165,700	-115,000
Principal received on loans receivable	1,466	1,469
Investment in loans receivable	-80,301	-2,385
Construction in progress and other	-46,511	-27,925
Net cash used for investing activities	-291,046	-143,841
Financing activities
Revolving credit facilities, net	-285,000	50,000
Payments of term debt	-71	-68
Distributions paid	-38,461	-35,778
Proceeds from sale of common shares / units, net of offering costs	479,966	112,583
Lease deposits and other obligations to tenants	-15,319	3,380
Debt issuance costs paid and other financing activities	-126	-241
Net cash provided by financing activities	140,989	129,876
Increase (decrease) in cash and cash equivalents for period	-108,031	4,317
Effect of exchange rate changes	-2,962	13
Cash and cash equivalents at beginning of period	144,541	45,979
Cash and cash equivalents at end of period	33,548	50,309
Interest paid	22,832	22,613
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	46,026	36,032
MPT Operating Partnership, L.P. [Member]
Operating activities
Net income	35,976	7,307
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	15,074	13,972
Direct financing lease interest accretion	-1,604	-1,604
Straight-line rent revenue	-4,728	-3,099
Straight-line rent write-off		950
Impairment charges		20,496
Share (Unit)-based compensation	2,825	2,287
Amortization and write-off of deferred financing costs and debt discount	1,377	1,049
Other adjustments	-1,290	1,239
Changes in
Interest and rent receivables	667	-4,674
Accounts payable and accrued expenses	-6,271	-19,641
Net cash provided by operating activities	42,026	18,282
Investing activities
Cash paid for acquisitions and other related investments	-165,700	-115,000
Principal received on loans receivable	1,466	1,469
Investment in loans receivable	-80,301	-2,385
Construction in progress and other	-46,511	-27,925
Net cash used for investing activities	-291,046	-143,841
Financing activities
Revolving credit facilities, net	-285,000	50,000
Payments of term debt	-71	-68
Distributions paid	-38,461	-35,778
Proceeds from sale of common shares / units, net of offering costs	479,966	112,583
Lease deposits and other obligations to tenants	-15,319	3,380
Debt issuance costs paid and other financing activities	-126	-241
Net cash provided by financing activities	140,989	129,876
Increase (decrease) in cash and cash equivalents for period	-108,031	4,317
Effect of exchange rate changes	-2,962	13
Cash and cash equivalents at beginning of period	144,541	45,979
Cash and cash equivalents at end of period	33,548	50,309
Interest paid	22,832	22,613
Supplemental schedule of non-cash financing activities:
Distributions declared, unpaid	$46,026	$36,032

Organization

Organization	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Organization	1. Organization
	Medical Properties Trust, Inc., a Maryland corporation, was formed on August 27, 2003, under the Maryland General Corporation Law for the purpose of engaging in the business of investing in, owning, and leasing commercial real estate. Our operating partnership subsidiary, MPT Operating Partnership, L.P., (the “Operating Partnership”) through which we conduct all of our operations, was formed in September 2003. Through another wholly-owned subsidiary, Medical Properties Trust, LLC, we are the sole general partner of the Operating Partnership. At present, we directly own substantially all of the limited partnership interests in the Operating Partnership and have elected to report our required disclosures and that of the Operating Partnership on a combined basis except where material differences exist.
	We have operated as a real estate investment trust (“REIT”) since April 6, 2004, and accordingly, elected REIT status upon the filing in September 2005 of the calendar year 2004 federal income tax return. Accordingly, we will generally not be subject to U.S. federal income tax, provided that we continue to qualify as a REIT and our distributions to our stockholders equal or exceed our taxable income. Certain activites we undertake must be conducted by entities which we elected to be treated as taxable REIT subsidiaries (“TRSs”). Our TRSs are subject to both U.S. federal and state income taxes.
	Our primary business strategy is to acquire and develop real estate and improvements, primarily for long-term lease to providers of healthcare services such as operators of general acute care hospitals, inpatient physical rehabilitation hospitals, long-term acute care hospitals, surgery centers, centers for treatment of specific conditions such as cardiac, pulmonary, cancer, and neurological hospitals, and other healthcare-oriented facilities. We also make mortgage and other loans to operators of similar facilities. In addition, we may obtain profits or equity interests in our tenants, from time to time, in order to enhance our overall return. We manage our business as a single business segment. All of our properties are located in the United States and Europe.

Summary_of_Significant_Account

Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	2. Summary of Significant Accounting Policies
	Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information, including rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles (“GAAP”) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 31, 2015, are not necessarily indicative of the results that may be expected for the year ending December 31, 2015. The condensed consolidated balance sheet at December 31, 2014 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.
	For information about significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014. During the three months ended March 31, 2015, there were no material changes to these policies.
	Recent Accounting Developments:
	Revenue from Contracts with Customers
	In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers.” Under the new standard, revenue is recognized at the time a good or service is transferred to a customer for the amount of consideration received for that specific good or service. Entities may use a full retrospective approach or report the cumulative effect as of the date of adoption.
	On April 1, 2015, the FASB proposed deferring the effective date by one year to December 15, 2017, for annual reporting periods beginning after that date. The FASB also proposed permitting early adoption of the standard, but not before the original effective date of December 15, 2016. We are currently evaluating the impact, if any, the adoption of this standard will have on our consolidated financial statements.
	Presentation of Debt Issuance Costs
	In April 2015, the FASB issued ASU No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs.” This standard amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability instead of a deferred charge. It is effective for annual reporting periods beginning after December 15, 2015, but early adoption is permitted.
	Amendments to the Consolidation Analysis
	In February 2015, the FASB issued an ASU 2015-02 that modifies the evaluation of whether limited partnerships and similar legal entities are VIEs, eliminates the presumption that a general partner should consolidate a limited partnership and affects the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships. The guidance is effective for fiscal years beginning after December 15, 2015, but early adoption is permitted.
	Variable Interest Entities
	At March 31, 2015, we had loans to and/or equity investments in certain variable interest entities (“VIEs”), which are also tenants of our facilities, including Ernest. We have determined that we are not the primary beneficiary of these VIEs. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at March 31, 2015 (in thousands):
	VIE Type		Maximum Loss		Asset Type	Carrying
			Exposure(1)		Classification	Amount(2)
	Loans, net		$	264,397	Mortgage and other loans	$	212,196
	Equity investments		$	59,228	Other assets	$	5,324
	-1	Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rents receivable), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represents the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.
	-2	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.
	For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrowers or investees) that most significantly impact the VIE’s economic performance. As of March 31, 2015, we were not required to provide financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls).
	Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower.
	See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

Real_Estate_and_Lending_Activi

Real Estate and Lending Activities

3 Months Ended

Mar. 31, 2015

Text Block [Abstract]

Real Estate and Lending Activities

3. Real Estate and Lending Activities

Acquisitions

2015 Activity

On February 13, 2015, we acquired two general acute care hospitals in the Kansas City area for $110 million. Affiliates of Prime Healthcare Services, Inc. (“Prime”) is the tenant and operator pursuant to a new master lease that has similar terms and security enhancements as the other master lease agreements entered into in 2013. This master lease has a 10 year initial fixed term with two extension options of five years each. The lease provides for consumer-price-indexed annual rent increases, subject to a specified floor. In addition, we agreed to fund a mortgage loan in the amount of $40 million, which has a 10-year term.

On February 27, 2015, we acquired an inpatient rehabilitation hospital in Weslaco, Texas for $10.7 million leased to Ernest Health Inc. (“Ernest”) pursuant to the 2012 master lease which has a remaining 17-year fixed term and three five year extension options. This lease provides for consumer-priced-indexed annual rent increases, subject to a floor and a cap. In addition we agreed to fund an acquisition loan in the amount of $5 million.

In January 2015, we advanced the remaining €63.1 million of the €425 million interim acquisition loans to MEDIAN. In April 2015, we executed definitive agreements with MEDIAN to purchase and lease back 31 hospitals and expect these properties to close during the next 30 to 60 days, subject to expiration or waiver of local government preemptive rights. As these 31 hospitals (and others) close, the related purchase prices will be offset, pro rata, against any debt that we assume on these properties or against the interim acquisition loans that have been made.

2014 Activity

On March 31, 2014, we acquired a general acute care hospital and an adjacent parcel for an aggregate purchase price of $115 million from a joint venture of LHP Hospital Group, Inc. and Hackensack University Medical Center Mountainside. The facility was simultaneously leased back to the seller under a lease with a 15-year initial term with a 3-year extension option, followed by a further 12-year extension option at fair market value. The lease provides for consumer-price-indexed annual rent increases, subject to a specified floor and ceiling. The lease includes a customary right of first refusal with respect to a subsequent proposed sale of the facility.

As part of these acquisitions, we acquired the following assets:

2015

2014

Assets Acquired

Land

$

21,591

$

8,515

Building

88,409

99,602

Intangible lease assets — subject to amortization (weighted average useful life 15 years)

—

6,883

Mortgage loans

40,000

—

Net investments in direct financing leases

10,700

—

Other loans

5,000

—

Total assets acquired

$

165,700

$

115,000

The purchase price allocations attributable to the 2015 acquisitions are preliminary. When all relevant information is obtained, resulting changes, if any, to our provisional purchase price allocation will be retrospectively adjusted to reflect new information obtained about the facts and circumstances that existed as of the respective acquisition dates that, if known, would have affected the measurement of the amounts recognized as of those dates.

Development Activities

During the 2015 first quarter, we completed construction and began recording rental income on two acute care facilities for First Choice ER (a subsidiary of Adeptus Health). These facilities are leased pursuant to the master lease entered into in 2014 and are cross-defaulted with the original master lease executed with First Choice ER in 2013.

In the first quarter of 2015, we began construction on six additional facilities pursuant to the master funding and development agreement with First Choice ER executed in 2014.

See table below for a status update on our current development projects (in thousands):

Property

Location

Property Type

Operator

Commitment

Costs

Estimated

Incurred

Completion

as of

Date

3/31/15

UAB Medical West

Hoover, AL

Acute Care Hospital & MOB

Medical West, an affiliate of UAB

$

8,653

$

5,853

2Q 2015

First Choice ER- Chandler

Chandler, AZ

Acute Care Hospital

Adeptus Health

5,049

2,502

2Q 2015

First Choice ER- Converse

Converse, TX

Acute Care Hospital

Adeptus Health

5,754

4,311

2Q 2015

First Choice ER- Denver 48th

Denver, CO

Acute Care Hospital

Adeptus Health

5,123

1,174

2Q 2015

First Choice ER- Aurora

Aurora, CO

Acute Care Hospital

Adeptus Health

5,273

21

3Q 2015

First Choice ER- Conroe

Houston, TX

Acute Care Hospital

Adeptus Health

6,110

1,668

3Q 2015

First Choice ER- Carrollton

Carrollton, TX

Acute Care Hospital

Adeptus Health

35,820

23,458

3Q 2015

First Choice ER- Gilbert

Gilbert, AZ

Acute Care Hospital

Adeptus Health

6,500

2,481

3Q 2015

First Choice ER- Glendale

Glendale, AZ

Acute Care Hospital

Adeptus Health

4,824

564

3Q 2015

First Choice ER- McKinney

McKinney, TX

Acute Care Hospital

Adeptus Health

4,750

1,002

3Q 2015

First Choice ER- Victory Lakes

Houston, TX

Acute Care Hospital

Adeptus Health

4,939

554

3Q 2015

First Choice ER- Vintage Preserve

Houston, TX

Acute Care Hospital

Adeptus Health

45,961

5,678

3Q 2016

First Choice Emergency Rooms

Various

Acute Care Hospital

Adeptus Health

13,448

—

Various

$

152,204

$

49,266

Leasing Operations

All of our leases are accounted for as operating leases except for the master lease of 15 Ernest facilities and five Prime facilities which are accounted for as direct financing leases (“DFLs”). The components of our net investment in DFLs consisted of the following (dollars in thousands):

As of March 31,

As of December 31,

2015

2014

Minimum lease payments receivable

$

1,639,128

$

1,607,024

Estimated residual values

225,871

211,888

Less: Unearned income

(1,411,576

)

(1,379,396

)

Net investment in direct financing leases

$

453,423

$

439,516

Florence facility

On March 6, 2013, the tenant of our $27.2 million facility in Phoenix, Arizona filed for Chapter 11 bankruptcy. At March 31, 2015, we have approximately $1.1 million of receivables outstanding but the tenant continues to pay us in accordance with bankruptcy orders. In addition, we have a letter of credit for approximately $1.2 million to cover any rent and other monetary payments not paid. We have entered into a non-binding letter of intent with the stalking horse bidder for the assumption of the existing lease, with certain non-monetary amendments. Although no assurances can be made that we will not have any impairment charges in the future, we believe our investment in Florence at March 31, 2015 is fully recoverable.

Gilbert facility

In the first quarter of 2014, the tenant of our facility in Gilbert, Arizona filed for Chapter 11 bankruptcy; however, we sent notice of termination of the lease prior to the bankruptcy filing. As a result of the lease terminating, we recorded a charge of approximately $1 million to reserve against the straight-line rent receivables. In addition, we accelerated the amortization of the related lease intangible asset resulting in $1.1 million of additional expense in the 2014 first quarter. The tenant has continued to perform its monetary obligations, and we have agreed to the terms of an amended lease upon the tenant’s bankruptcy exit. Although no assurances can be made that we will not have any impairment charges or write-offs of receivables in the future, we believe our real estate investment in Gilbert of $14.1 million at March 31, 2015 is fully recoverable.

Loans

The following is a summary of our loans (in thousands):

As of

As of

March 31,

December 31,

2015

2014

Mortgage loans

$

437,591

$

397,594

Acquisition loans

555,391

525,136

Working capital and other loans

46,566

48,031

$

1,039,548

$

970,761

Our non-mortgage loans typically consist of loans to our tenants for acquisitions and working capital purposes. At March 31, 2015, acquisition loans includes our $102.5 million loans to Ernest plus $442.4 million related to the MEDIAN Kliniken S.à r.l. (“MEDIAN”), transaction in 2014.

On March 1, 2012, pursuant to our convertible note agreement, we converted $1.7 million of our $5.0 million convertible note into a 9.9% equity interest in the operator of our Hoboken University Medical Center facility. At March 31, 2015, $3.3 million remains outstanding on the convertible note, and we retain the option, subject to regulatory approvals, to convert this remainder into 15.1% of equity interest in the operator.

Concentrations of Credit Risk

For the three months ended March 31, 2015 and 2014, revenue from affiliates of Prime (including rent and interest from mortgage loans) accounted for 25.0% and 29.1%, respectively, of total revenue. From an investment concentration perspective, assets leased and loaned to Prime represented 15.2% and 8.3%, respectively of our total assets, at March 31, 2015. Assets leased and loaned to Prime represented 12.6% and 7.4%, respectively, of our total assets at December 31, 2014.

For the three months ended March 31, 2015, revenue from affiliates of MEDIAN accounted for 9.5% of total revenue. From an investment concentration perspective, MEDIAN represented 11.6% and 11.3% of our total assets at March 31, 2015 and December 31, 2014, respectively.

For the three months ended March 31, 2015 and 2014, revenue from affiliates of Ernest (including rent and interest from mortgage and acquisition loans) accounted for 15.3% and 19.6% of total revenue, respectively. From an investment concentration perspective, assets leased and loaned to Ernest represented 7.9% and 5.3%, respectively, of our total assets at March 31, 2015. Assets leased and loaned to Ernest represented 7.7% and 5.3%, respectively, of our total assets at December 31, 2014.

On an individual property basis, we had no investment of any single property greater than 4% of our total assets as of March 31, 2015.

From a global geographic perspective, approximately 80% of our total assets are in the United States while 20% reside in Europe as of March 31, 2015 and December 31, 2014. Revenue from our European investments was $16.3 million and $5.5 million in the first quarter of 2015 and 2014, respectively.

From a United States geographic perspective, investments located in California represented 14.3% of our total assets at March 31, 2015, compared to 14.6% at December 31, 2014. Investments located in Texas represented 20.5% of our total assets at March 31, 2015, compared to 20.2% at December 31, 2014.

Debt

Debt	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Debt	4. Debt
	The following is a summary of debt, net of discounts (dollar amounts in thousands):
			As of March 31, 2015				As of December 31, 2014
			Balance		Interest Rate		Balance		Interest Rate
	Revolving credit facility		$	301,655		Variable	$	593,490		Variable
	2006 Senior Unsecured Notes			125,000		Various		125,000		Various
	2011 Senior Unsecured Notes			450,000		6.88%		450,000		6.88%
	2012 Senior Unsecured Notes:
	Principal amount			350,000		6.38%		350,000		6.38%
	Unamortized premium			2,433				2,522
				352,433				352,522
	2013 Senior Unsecured Notes (A)			214,620		5.75%		241,960		5.75%
	2014 Senior Unsecured Notes			300,000		5.50%		300,000		5.50%
	Term loans			138,611		Various		138,682		Various
			$	1,882,319			$	2,201,654
	(A)	These notes are Euro-denominated and reflect the exchange rate at March 31, 2015 and December 31, 2014, respectively.
	As of March 31, 2015, principal payments due on our debt (which exclude the effects of any discounts or premiums recorded) are as follows (in thousands):
	2015		$	211
	2016			125,299
	2017			320
	2018			314,436
	2019			125,000
	Thereafter			1,314,620
	Total		$	1,879,886
	During the second quarter 2010, we entered into an interest rate swap to manage our exposure to variable interest rates by fixing $65 million of our 2006 Senior Unsecured Notes, which started July 31, 2011 (date on which the interest rate turned variable) through maturity date (or July 2016), at a rate of 5.507%. We also entered into an interest rate swap to fix $60 million of our 2006 Senior Unsecured Notes which started October 31, 2011 (date on which the related interest rate turned variable) through the maturity date (or October 2016) at a rate of 5.675%. The fair value of the interest rate swaps was $5.5 million and $6.0 million as of March 31, 2015 and December 31, 2014, respectively, which is reflected in accounts payable and accrued expenses on the consolidated balance sheets.
	We account for our interest rate swaps as cash flow hedges. Accordingly, the effective portion of changes in the fair value of our swaps is recorded as a component of accumulated other comprehensive income/loss on the balance sheet and reclassified into earnings in the same period, or periods, during which the hedged transactions effect earnings, while any ineffective portion is recorded through earnings immediately. We did not have any hedge ineffectiveness from inception of our interest rate swaps through March 31, 2015 and therefore, there was no income statement effect recorded during the three month periods ended March 31, 2015 or 2014. We do not expect any of the current losses included in accumulated other comprehensive loss to be reclassified into earnings in the next 12 months. At March 31, 2015 and December 31, 2014, we have posted $2.8 million and $3.3 million of collateral related to our interest rate swaps, respectively, which is reflected in other assets on our consolidated balance sheets.
	Covenants
	Our debt facilities impose certain restrictions on us, including restrictions on our ability to: incur debts; create or incur liens; provide guarantees in respect of obligations of any other entity; make redemptions and repurchases of our capital stock; prepay, redeem or repurchase debt; engage in mergers or consolidations; enter into affiliated transactions; dispose of real estate or other assets; and change our business. In addition, the credit agreements governing our revolving credit facility and term loan limit the amount of dividends we can pay as a percentage of normalized adjusted funds from operations, as defined in the agreements, on a rolling four quarter basis. At March 31, 2015, the dividend restriction was 95% of normalized adjusted FFO. The indentures governing our senior unsecured notes also limit the amount of dividends we can pay based on the sum of 95% of funds from operations, proceeds of equity issuances and certain other net cash proceeds. Finally, our senior unsecured notes require us to maintain total unencumbered assets (as defined in the related indenture) of not less than 150% of our unsecured indebtedness.
	In addition to these restrictions, the revolving credit facility and term loan contain customary financial and operating covenants, including covenants relating to our total leverage ratio, fixed charge coverage ratio, mortgage secured leverage ratio, recourse mortgage secured leverage ratio, consolidated adjusted net worth, facility leverage ratio, and unsecured interest coverage ratio. This facility also contains customary events of default, including among others, nonpayment of principal or interest, material inaccuracy of representations and failure to comply with our covenants. If an event of default occurs and is continuing under the facility, the entire outstanding balance may become immediately due and payable. At March 31, 2015, we were in compliance with all such financial and operating covenants.

Common_StockPartners_Capital

Common Stock/Partner's Capital	3 Months Ended
	Mar. 31, 2015
Equity [Abstract]
Common Stock/Partner's Capital	5. Common Stock/Partner’s Capital
	Medical Properties Trust, Inc.
	On January 14, 2015, we completed an underwritten public offering of 34.5 million shares (including the exercise of the underwriters’ 30-day option to purchase an additional 4.5 million shares) of our common stock, resulting in net proceeds of approximately $480 million, after deducting estimated offering expenses.
	On March 11, 2014, we completed an underwritten public offering of 7.7 million shares of our common stock, resulting in net proceeds of approximately $100.2 million, after deducting estimated offering expenses. We also granted the underwriters a 30-day option to purchase up to an additional 1.2 million shares of common stock. The option, which was exercised in full, closed on April 8, 2014 and resulted in additional net proceeds of approximately $16 million.
	In January 2014, we put an at-the-market equity offering program in place, giving us the ability to sell up to $250 million of stock with a commission of 1.25%. During the 2014 first quarter, we sold 0.9 million shares of our common stock under our at-the-market equity offering program, at an average price of $13.21 per share resulting in total proceeds, net of commission, of $12.3 million. There were no shares issued under the at-the-market equity offering program during the 2015 first quarter.
	MPT Operating Partnership, L.P.
	At March 31, 2015, the Company has a 99.8% ownership interest in the Operating Partnership with the remainder owned by three other partners, two of whom are employees and one of whom is a director. During the three months ended March 31, 2015 and 2014, the partnership issued 34.5 million and 8.6 million units, respectively, in direct response to the common stock offerings by Medical Properties Trust, Inc.

Stock_Awards

Stock Awards	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Awards	6. Stock Awards
	We adopted the 2013 Equity Incentive Plan (the “Equity Incentive Plan”) during second quarter of 2013, which authorizes the issuance of common stock options, restricted stock, restricted stock units, deferred stock units, stock appreciation rights, performance units and awards of interests in our Operating Partnership. The Equity Incentive Plan is administered by the Compensation Committee of the Board of Directors. We have reserved 7,643,651 shares of common stock for awards under the Equity Incentive Plan for which 5,417,878 shares remain available for future stock awards as of March 31, 2015. We awarded the following during the 2015 and 2014 first quarters:
	Time-based awards—We granted 217,177 and 338,484 shares in 2015 and 2014, respectively, of time-based restricted stock to management, independent directors and certain employees. These awards vest quarterly based on service, over three years, in equal amounts.
	Performance-based awards—Our management team and certain employees were awarded 176,046 and 317,254 performance based awards in 2015 and 2014, respectively. These awards vest ratably over a three year period based on the achievement of certain total shareholder return measures, with a carry-back and carry-forward provision through December 31, 2018 (for the 2014 awards) and December 31, 2017 (for the 2015 awards). Dividends on these awards are paid only upon achievement of the performance measures.
	Multi-year Performance-based awards—We awarded 505,050 and 500,000 shares in 2015 and 2014, respectively, of multi-year performance-based awards to management. These shares are subject to three-year cumulative performance hurdles based on measures of total shareholder return. At the end of the three-year performance period, any earned shares will be subject to an additional two years of ratable time-based vesting on an annual basis. Dividends are paid on these shares only upon achievement of the performance measures.

Fair_Value_of_Financial_Instru

Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	7. Fair Value of Financial Instruments
	We have various assets and liabilities that are considered financial instruments. We estimate that the carrying value of cash and cash equivalents, and accounts payable and accrued expenses approximate their fair values. Included in our accounts payable and accrued expenses are our interest rate swaps, which are recorded at fair value based on Level 2 observable market assumptions using standardized derivative pricing models. We estimate the fair value of our interest and rent receivables using Level 2 inputs such as discounting the estimated future cash flows using the current rates at which similar receivables would be made to others with similar credit ratings and for the same remaining maturities. The fair value of our mortgage loans and working capital loans are estimated by using Level 2 inputs such as discounting the estimated future cash flows using the current rates which similar loans would be made to borrowers with similar credit ratings and for the same remaining maturities. We determine the fair value of our senior unsecured notes (excluding our 2006 Senior Unsecured Notes) using Level 2 inputs such as quotes from securities dealers and market makers. We estimate the fair value of our 2006 Senior Unsecured Notes, revolving credit facilities, and term loans using Level 2 inputs based on the present value of future payments, discounted at a rate which we consider appropriate for such debt.
	Fair value estimates are made at a specific point in time, are subjective in nature, and involve uncertainties and matters of significant judgment. Settlement of such fair value amounts may not be possible and may not be a prudent management decision. The following table summarizes fair value estimates for our financial instruments (in thousands):
			March 31,						December 31,
			2015						2014
	Asset (Liability)		Book			Fair			Book			Fair
			Value			Value			Value			Value
	Interest and rent receivables		$	40,464		$	40,324		$	41,137		$	41,005
	Loans (1)			837,098			867,523			773,311			803,824
	Debt, net			(1,882,319	)		(1,981,158	)		(2,201,654	)		(2,285,727	)
	-1	Excludes loans related to Ernest since they are recorded at fair value and discussed below.
	Items Measured at Fair Value on a Recurring Basis
	Our equity interest in Ernest and related loans, which were acquired in 2012, are being measured at fair value on a recurring basis as we elected to account for these investments using the fair value option method. We have elected to account for these investments at fair value due to the size of the investments and because we believe this method is more reflective of current values. We have not made a similar election for other equity interests or loans in or prior to 2015.
	At March 31, 2015, these amounts were as follows (in thousands):
	Asset Type		Fair			Cost			Asset Type
			Value						Classification
	Mortgage loans		$	100,000		$	100,000		Mortgage loans
	Acquisition loan			102,450			102,450		Other loans
	Equity investments			3,300			3,300		Other assets
			$	205,750		$	205,750
	Our mortgage loans with Ernest are recorded at fair value based on Level 3 inputs by discounting the estimated cash flows using the market rates which similar loans would be made to borrowers with similar credit ratings and the same remaining maturities. Our acquisition loans and equity investments in Ernest are recorded at fair value based on Level 3 inputs, by using a discounted cash flow model, which requires significant estimates of our investee such as projected revenue and expenses and appropriate consideration of the underlying risk profile of the forecast assumptions associated with the investee. We classify these loans and equity investments as Level 3, as we use certain unobservable inputs to the valuation methodology that are significant to the fair value measurement, and the valuation requires management judgment due to the absence of quoted market prices. For these cash flow models, our observable inputs include use of a capitalization rate, discount rate (which is based on a weighted-average cost of capital), and market interest rates, and our unobservable input includes an adjustment for a marketability discount (“DLOM”) on our equity investment of 40% at March 31, 2015.
	In regards to the underlying projection of revenues and expenses used in the discounted cash flow model, such projections are provided by Ernest. However, we will modify such projections (including underlying assumptions used) as needed based on our review and analysis of Ernest’s historical results, meetings with key members of management, and our understanding of trends and developments within the healthcare industry.
	In arriving at the DLOM, we started with a DLOM range based on the results of studies supporting valuation discounts for other transactions or structures without a public market. To select the appropriate DLOM within the range, we then considered many qualitative factors including the percent of control, the nature of the underlying investee’s business along with our rights as an investor pursuant to the operating agreement, the size of investment, expected holding period, number of shareholders, access to capital marketplace, etc. To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands):
	Basis Point		Estimated Increase (Decrease)
			In Fair Value
	Change in
	Marketability Discount
	+100 basis points		$	(443	)
	- 100 basis points			443
	Because the fair value of Ernest investments noted above approximate their original cost, we did not recognize any unrealized gains/losses during the first quarter of 2015 or 2014. To date, we have not received any distribution payments from our equity investment in Ernest.

Earnings_Per_Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Earnings Per Share	8. Earnings Per Share
	Medical Properties Trust, Inc.
	Our earnings per share were calculated based on the following (amounts in thousands):
		For the Three Months
		Ended March 31,
		2015			2014
	Numerator:
	Income from continuing operations	$	35,976		$	7,309
	Non-controlling interests’ share in continuing operations		(79	)		(66	)
	Participating securities’ share in earnings		(266	)		(209	)
	Income from continuing operations, less participating securities’ share in earnings		35,631			7,034
	Income (loss) from discontinued operations		—			(2	)
	Net income, less participating securities’ share in earnings	$	35,631		$	7,032
	Denominator:
	Basic weighted-average common shares		202,958			163,973
	Dilutive potential common shares		657			576
	Dilutive weighted-average common shares		203,615			164,549
	MPT Operating Partnership, L.P.
	Our earnings per common unit were calculated based on the following (amounts in thousands):
		For the Three Months
		Ended March 31,
		2015			2014
	Numerator:
	Income from continuing operations	$	35,976		$	7,309
	Non-controlling interests’ share in continuing operations		(79	)		(66	)
	Participating securities’ share in earnings		(266	)		(209	)
	Income from continuing operations, less participating securities’ share in earnings		35,631			7,034
	Income (loss) from discontinued operations		—			(2	)
	Net income, less participating securities’ share in earnings	$	35,631		$	7,032
	Denominator:
	Basic weighted-average units		202,958			163,973
	Dilutive potential units		657			576
	Diluted weighted-average units		203,615			164,549

Contingencies

Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Contingencies	9. Contingencies
	We are a party to various legal proceedings incidental to our business. In the opinion of management, after consultation with legal counsel, the ultimate liability, if any, with respect to those proceedings is not presently expected to materially affect our financial position, results of operations or cash flows.

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events	10. Subsequent Events
	In April 2015, we executed an agreement with Adeptus Health that provides for the acquisition and development of general acute care hospitals and free standing emergency facilities with an aggregate commitment of $250 million. These facilities will be leased to Adeptus Health pursuant to the terms of the 2014 master lease agreement that has a 15-year initial term with three extension options of five years each that provides for annual rent increases based on changes in the consumer price index with a 2% minimum.

Summary_of_Significant_Account1

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Unaudited Interim Condensed Consolidated Financial Statements	Unaudited Interim Condensed Consolidated Financial Statements: The accompanying unaudited interim condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information, including rules and regulations of the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles (“GAAP”) for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the three month period ended March 31, 2015, are not necessarily indicative of the results that may be expected for the year ending December 31, 2015. The condensed consolidated balance sheet at December 31, 2014 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by accounting principles generally accepted in the United States for complete financial statements.
	For information about significant accounting policies, refer to the consolidated financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2014. During the three months ended March 31, 2015, there were no material changes to these policies.
Recent Accounting Developments	Recent Accounting Developments:
	Revenue from Contracts with Customers
	In May 2014, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2014-09, “Revenue from Contracts with Customers.” Under the new standard, revenue is recognized at the time a good or service is transferred to a customer for the amount of consideration received for that specific good or service. Entities may use a full retrospective approach or report the cumulative effect as of the date of adoption.
	On April 1, 2015, the FASB proposed deferring the effective date by one year to December 15, 2017, for annual reporting periods beginning after that date. The FASB also proposed permitting early adoption of the standard, but not before the original effective date of December 15, 2016. We are currently evaluating the impact, if any, the adoption of this standard will have on our consolidated financial statements.
	Presentation of Debt Issuance Costs
	In April 2015, the FASB issued ASU No. 2015-03, “Simplifying the Presentation of Debt Issuance Costs.” This standard amends existing guidance to require the presentation of debt issuance costs in the balance sheet as a deduction from the carrying amount of the related debt liability instead of a deferred charge. It is effective for annual reporting periods beginning after December 15, 2015, but early adoption is permitted.
	Amendments to the Consolidation Analysis
	In February 2015, the FASB issued an ASU 2015-02 that modifies the evaluation of whether limited partnerships and similar legal entities are VIEs, eliminates the presumption that a general partner should consolidate a limited partnership and affects the consolidation analysis of reporting entities that are involved with VIEs, particularly those that have fee arrangements and related party relationships. The guidance is effective for fiscal years beginning after December 15, 2015, but early adoption is permitted.
Variable Interest Entities	Variable Interest Entities
	At March 31, 2015, we had loans to and/or equity investments in certain variable interest entities (“VIEs”), which are also tenants of our facilities, including Ernest. We have determined that we are not the primary beneficiary of these VIEs. The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at March 31, 2015 (in thousands):
	VIE Type		Maximum Loss		Asset Type	Carrying
			Exposure(1)		Classification	Amount(2)
	Loans, net		$	264,397	Mortgage and other loans	$	212,196
	Equity investments		$	59,228	Other assets	$	5,324
	-1	Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rents receivable), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represents the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.
	-2	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.
	For the VIE types above, we do not consolidate the VIE because we do not have the ability to control the activities (such as the day-to-day healthcare operations of our borrowers or investees) that most significantly impact the VIE’s economic performance. As of March 31, 2015, we were not required to provide financial support through a liquidity arrangement or otherwise to our unconsolidated VIEs, including circumstances in which it could be exposed to further losses (e.g., cash short falls).
	Typically, our loans are collateralized by assets of the borrower (some assets of which are on the premises of facilities owned by us) and further supported by limited guarantees made by certain principals of the borrower.
	See Note 3 for additional description of the nature, purpose and activities of our more significant VIEs and interests therein.

Summary_of_Significant_Account2

Summary of Significant Accounting Policies (Tables)	3 Months Ended
	Mar. 31, 2015
Accounting Policies [Abstract]
Carrying Value and Classification of Related Assets and Maximum Exposure to Loss	The carrying value and classification of the related assets and maximum exposure to loss as a result of our involvement with these VIEs are presented below at March 31, 2015 (in thousands):
	VIE Type		Maximum Loss		Asset Type	Carrying
			Exposure(1)		Classification	Amount(2)
	Loans, net		$	264,397	Mortgage and other loans	$	212,196
	Equity investments		$	59,228	Other assets	$	5,324
	-1	Our maximum loss exposure related to loans with VIEs represents our current aggregate gross carrying value of the loan plus accrued interest and any other related assets (such as rents receivable), less any liabilities. Our maximum loss exposure related to our equity investment in VIEs represents the current carrying values of such investment plus any other related assets (such as rent receivables) less any liabilities.
	-2	Carrying amount reflects the net book value of our loan or equity interest only in the VIE.

Real_Estate_and_Lending_Activi1

Real Estate and Lending Activities (Tables)	3 Months Ended
	Mar. 31, 2015
Text Block [Abstract]
Assets Acquired	As part of these acquisitions, we acquired the following assets:
		2015			2014
	Assets Acquired
	Land	$	21,591		$	8,515
	Building		88,409			99,602
	Intangible lease assets — subject to amortization (weighted average useful life 15 years)		—			6,883
	Mortgage loans		40,000			—
	Net investments in direct financing leases		10,700			—
	Other loans		5,000			—
	Total assets acquired	$	165,700		$	115,000
Summary of Status Update on Current Development Projects	See table below for a status update on our current development projects (in thousands):
	Property	Location		Property Type	Operator		Commitment		Costs		Estimated
									Incurred		Completion
									as of		Date
									3/31/15
	UAB Medical West	Hoover, AL		Acute Care Hospital & MOB	Medical West, an affiliate of UAB		$	8,653	$	5,853		2Q 2015
	First Choice ER- Chandler	Chandler, AZ		Acute Care Hospital	Adeptus Health			5,049		2,502		2Q 2015
	First Choice ER- Converse	Converse, TX		Acute Care Hospital	Adeptus Health			5,754		4,311		2Q 2015
	First Choice ER- Denver 48th	Denver, CO		Acute Care Hospital	Adeptus Health			5,123		1,174		2Q 2015
	First Choice ER- Aurora	Aurora, CO		Acute Care Hospital	Adeptus Health			5,273		21		3Q 2015
	First Choice ER- Conroe	Houston, TX		Acute Care Hospital	Adeptus Health			6,110		1,668		3Q 2015
	First Choice ER- Carrollton	Carrollton, TX		Acute Care Hospital	Adeptus Health			35,820		23,458		3Q 2015
	First Choice ER- Gilbert	Gilbert, AZ		Acute Care Hospital	Adeptus Health			6,500		2,481		3Q 2015
	First Choice ER- Glendale	Glendale, AZ		Acute Care Hospital	Adeptus Health			4,824		564		3Q 2015
	First Choice ER- McKinney	McKinney, TX		Acute Care Hospital	Adeptus Health			4,750		1,002		3Q 2015
	First Choice ER- Victory Lakes	Houston, TX		Acute Care Hospital	Adeptus Health			4,939		554		3Q 2015
	First Choice ER- Vintage Preserve	Houston, TX		Acute Care Hospital	Adeptus Health			45,961		5,678		3Q 2016
	First Choice Emergency Rooms	Various		Acute Care Hospital	Adeptus Health			13,448		—		Various
							$	152,204	$	49,266
Components of Net Investment in Direct Financing Leases	The components of our net investment in DFLs consisted of the following (dollars in thousands):
		As of March 31,			As of December 31,
		2015			2014
	Minimum lease payments receivable	$	1,639,128		$	1,607,024
	Estimated residual values		225,871			211,888
	Less: Unearned income		(1,411,576	)		(1,379,396	)
	Net investment in direct financing leases	$	453,423		$	439,516
Summary of Loans	The following is a summary of our loans (in thousands):
		As of			As of
		March 31,			December 31,
		2015			2014
	Mortgage loans	$	437,591		$	397,594
	Acquisition loans		555,391			525,136
	Working capital and other loans		46,566			48,031
		$	1,039,548		$	970,761

Debt_Tables

Debt (Tables)	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Summary of Debt	The following is a summary of debt, net of discounts (dollar amounts in thousands):
			As of March 31, 2015				As of December 31, 2014
			Balance		Interest Rate		Balance		Interest Rate
	Revolving credit facility		$	301,655		Variable	$	593,490		Variable
	2006 Senior Unsecured Notes			125,000		Various		125,000		Various
	2011 Senior Unsecured Notes			450,000		6.88%		450,000		6.88%
	2012 Senior Unsecured Notes:
	Principal amount			350,000		6.38%		350,000		6.38%
	Unamortized premium			2,433				2,522
				352,433				352,522
	2013 Senior Unsecured Notes (A)			214,620		5.75%		241,960		5.75%
	2014 Senior Unsecured Notes			300,000		5.50%		300,000		5.50%
	Term loans			138,611		Various		138,682		Various
			$	1,882,319			$	2,201,654
	(A)	These notes are Euro-denominated and reflect the exchange rate at March 31, 2015 and December 31, 2014, respectively.
Principal Payments Due for Debt	As of March 31, 2015, principal payments due on our debt (which exclude the effects of any discounts or premiums recorded) are as follows (in thousands):
	2015		$	211
	2016			125,299
	2017			320
	2018			314,436
	2019			125,000
	Thereafter			1,314,620
	Total		$	1,879,886

Fair_Value_of_Financial_Instru1

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
Summary of Fair Value Information of Financial Instruments	The following table summarizes fair value estimates for our financial instruments (in thousands):
			March 31,						December 31,
			2015						2014
	Asset (Liability)		Book			Fair			Book			Fair
			Value			Value			Value			Value
	Interest and rent receivables		$	40,464		$	40,324		$	41,137		$	41,005
	Loans (1)			837,098			867,523			773,311			803,824
	Debt, net			(1,882,319	)		(1,981,158	)		(2,201,654	)		(2,285,727	)
	-1	Excludes loans related to Ernest since they are recorded at fair value and discussed below.
Equity Interest in Ernest and Related Loans Measured at Fair Value on Recurring Basis	At March 31, 2015, these amounts were as follows (in thousands):
	Asset Type		Fair			Cost			Asset Type
			Value						Classification
	Mortgage loans		$	100,000		$	100,000		Mortgage loans
	Acquisition loan			102,450			102,450		Other loans
	Equity investments			3,300			3,300		Other assets
			$	205,750		$	205,750
Summary Showing Sensitivity Analysis by Using Basis Point Variations	To illustrate the effect of movements in the DLOM, we performed a sensitivity analysis below by using basis point variations (dollars in thousands):
	Basis Point		Estimated Increase (Decrease)
	Change in		In Fair Value
	Marketability Discount
	+100 basis points		$	(443	)
	- 100 basis points			443

Earnings_Per_Share_Tables

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Calculation of Earnings Per Share	Medical Properties Trust, Inc.
	Our earnings per share were calculated based on the following (amounts in thousands):
		For the Three Months
		Ended March 31,
		2015			2014
	Numerator:
	Income from continuing operations	$	35,976		$	7,309
	Non-controlling interests’ share in continuing operations		(79	)		(66	)
	Participating securities’ share in earnings		(266	)		(209	)
	Income from continuing operations, less participating securities’ share in earnings		35,631			7,034
	Income (loss) from discontinued operations		—			(2	)
	Net income, less participating securities’ share in earnings	$	35,631		$	7,032
	Denominator:
	Basic weighted-average common shares		202,958			163,973
	Dilutive potential common shares		657			576
	Dilutive weighted-average common shares		203,615			164,549
	MPT Operating Partnership, L.P.
	Our earnings per common unit were calculated based on the following (amounts in thousands):
		For the Three Months
		Ended March 31,
		2015			2014
	Numerator:
	Income from continuing operations	$	35,976		$	7,309
	Non-controlling interests’ share in continuing operations		(79	)		(66	)
	Participating securities’ share in earnings		(266	)		(209	)
	Income from continuing operations, less participating securities’ share in earnings		35,631			7,034
	Income (loss) from discontinued operations		—			(2	)
	Net income, less participating securities’ share in earnings	$	35,631		$	7,032
	Denominator:
	Basic weighted-average units		202,958			163,973
	Dilutive potential units		657			576
	Diluted weighted-average units		203,615			164,549

Summary_of_Significant_Account3

Summary of Significant Accounting Policies - Carrying Value and Classification of Related Assets and Maximum Exposure to Loss (Detail) (USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
Mortgage and other loans [Member]
Variable Interest Entity [Line Items]
Carrying Amount	$212,196
Loans, net [Member]
Variable Interest Entity [Line Items]
Maximum Loss Exposure	264,397
Other assets [Member]
Variable Interest Entity [Line Items]
Carrying Amount	5,324
Equity investments [Member]
Variable Interest Entity [Line Items]
Maximum Loss Exposure	$59,228

Real_Estate_and_Lending_Activi2

Real Estate and Lending Activities - 2015 Activity - Additional Information (Detail) (2015 [Member])	0 Months Ended		0 Months Ended					0 Months Ended
In Millions, unless otherwise specified	Jan. 31, 2015	Jan. 31, 2015	Apr. 30, 2015	Apr. 30, 2015	Apr. 30, 2015	Feb. 13, 2015	Feb. 13, 2015	Feb. 27, 2015
	MEDIAN Transaction [Member]	MEDIAN Transaction [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Subsequent Event [Member]	Acute Care Hospital [Member]	Acute Care Hospital [Member]	Inpatient Rehabilitation Hospital [Member]
	EUR (€)	EUR (€)	MEDIAN Transaction [Member]	MEDIAN Transaction [Member]	MEDIAN Transaction [Member]	Kansas [Member]	Kansas [Member]	Ernest Health, Inc [Member]
			Hospital	Minimum [Member]	Maximum [Member]	USD ($)	USD ($)	Weslaco, Texas [Member]
						Facility	RenewalOptions	USD ($)
						RenewalOptions		Leases
Significant Acquisitions and Disposals [Line Items]
Number of facilities acquired						2
Purchase price of acquisition							$110
Term of lease, years						10 years
Number of lease extensions options in current lease contract							2
Term of lease extensions, years						5 years		5 years
Mortgage financing						40
Mortgage financing term						10 years
Acquisition costs								10.7
Payments to fund long-term loans to related parties								5
Lease remaining term								17 years
Number of lease extension options								3
Advanced interim acquisition loan	63.1
Interim acquisition loan		€ 425
Number of hospitals purchased and leased			31
Lease expiration period				30 days	60 days

Real_Estate_and_Lending_Activi3

Real Estate and Lending Activities - 2014 Activity - Additional Information (Detail) (USD $)	0 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
2014 [Member] | Acute Care Hospital [Member]
Significant Acquisitions and Disposals [Line Items]
Acquisition costs		$115
Term of lease, years	15 years
Term of lease extension, years	3 years
2014 [Member] | Acute Care Hospital [Member] | Fair value market [Member]
Significant Acquisitions and Disposals [Line Items]
Term of lease extension, years	12 years
Development Activities [Member] | First Choice [Member]
Significant Acquisitions and Disposals [Line Items]
Number of facilities leased	2
Development Activities [Member] | First Choice [Member] | Asset under Construction [Member]
Significant Acquisitions and Disposals [Line Items]
Number of facilities leased	6

Real_Estate_and_Lending_Activi4

Real Estate and Lending Activities - Assets Acquired (Detail) (USD $)	Mar. 31, 2015	Mar. 31, 2014
In Thousands, unless otherwise specified
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	$165,700	$115,000
Land [Member]
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	21,591	8,515
Building [Member]
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	88,409	99,602
Intangible lease assets - subject to amortization [Member]
Significant Acquisitions and Disposals [Line Items]
Total assets acquired		6,883
Net investments in direct financing leases [Member]
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	10,700
Other loans [Member]
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	5,000
Mortgage loans [Member]
Significant Acquisitions and Disposals [Line Items]
Total assets acquired	$40,000

Real_Estate_and_Lending_Activi5

Real Estate and Lending Activities - Assets Acquired (Parenthetical) (Detail) (Intangible lease assets - subject to amortization [Member])	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Intangible lease assets - subject to amortization [Member]
Significant Acquisitions and Disposals [Line Items]
Weighted average useful life of acquired intangible lease assets (in years)	15 years	15 years

Real_Estate_and_Lending_Activi6

Real Estate and Lending Activities - Summary of Status Update on Current Development Projects (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
Business Acquisition [Line Items]
Commitment	$152,204
Costs Incurred as of 03/31/2015	49,266
UAB Medical West [Member] | Hoover AL [Member] | Acute Care Hospital And MOB [Member] | Medical West, an Affiliate of UAB [Member]
Business Acquisition [Line Items]
Commitment	8,653
Costs Incurred as of 03/31/2015	5,853
Estimated Completion Date	2Q 2015
First Choice ER- Carrollton [Member] | Carrollton TX [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	35,820
Costs Incurred as of 03/31/2015	23,458
Estimated Completion Date	3Q 2015
First Choice ER- Chandler [Member] | Chandler AZ [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	5,049
Costs Incurred as of 03/31/2015	2,502
Estimated Completion Date	2Q 2015
First Choice ER- Converse [Member] | Converse TX [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	5,754
Costs Incurred as of 03/31/2015	4,311
Estimated Completion Date	2Q 2015
First Choice ER- Denver 48th [Member] | Denver, CO [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	5,123
Costs Incurred as of 03/31/2015	1,174
Estimated Completion Date	2Q 2015
First Choice ER- McKinney [Member] | McKinney TX [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	4,750
Costs Incurred as of 03/31/2015	1,002
Estimated Completion Date	3Q 2015
First Choice Emergency Rooms [Member] | Various [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	13,448
Costs Incurred as of 03/31/2015	0
Estimated Completion Date	Various
First Choice ER Aurora [Member] | Aurora CO [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	5,273
Costs Incurred as of 03/31/2015	21
Estimated Completion Date	3Q 2015
First Choice ER Conroe [Member] | Houston, TX [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	6,110
Costs Incurred as of 03/31/2015	1,668
Estimated Completion Date	3Q 2015
First Choice ER Conroe [Member] | Gilbert AZ [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	6,500
Costs Incurred as of 03/31/2015	2,481
Estimated Completion Date	3Q 2015
First Choice ER Glendale [Member] | Glendale AZ [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	4,824
Costs Incurred as of 03/31/2015	564
Estimated Completion Date	3Q 2015
First Choice ER Victory Lakes [Member] | Houston, TX [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	4,939
Costs Incurred as of 03/31/2015	554
Estimated Completion Date	3Q 2015
First Choice ER Vintage Preserve [Member] | Houston, TX [Member] | Acute Care Hospital [Member] | Adeptus Health [Member]
Business Acquisition [Line Items]
Commitment	45,961
Costs Incurred as of 03/31/2015	$5,678
Estimated Completion Date	3Q 2016

Real_Estate_and_Lending_Activi7

Real Estate and Lending Activities - Leasing Operations - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2015
	Leases
Ernest Health, Inc [Member]
Significant Acquisitions and Disposals [Line Items]
Number of direct financing leases	15
Prime Facilities [Member]
Significant Acquisitions and Disposals [Line Items]
Number of direct financing leases	5

Real_Estate_and_Lending_Activi8

Real Estate and Lending Activities - Components of Net Investment in Direct Financing Leases (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Business Combinations [Abstract]
Minimum lease payments receivable	$1,639,128	$1,607,024
Estimated residual values	225,871	211,888
Less: Unearned income	-1,411,576	-1,379,396
Net investment in direct financing leases	$453,423	$439,516

Real_Estate_and_Lending_Activi9

Real Estate and Lending Activities - Florence Facility - Additional Information (Detail) (Florence acute care facility [Member], USD $)	Mar. 31, 2015	Mar. 06, 2013
In Millions, unless otherwise specified
Florence acute care facility [Member]
Significant Acquisitions and Disposals [Line Items]
Letter of credit outstanding	$1.20
Business acquisition cost of acquired entity		27.2
Outstanding rent receivables		$1.10

Recovered_Sheet1

Real Estate and Lending Activities - Gilbert Facility - Additional Information (Detail) (Gilbert AZ [Member], USD $)	3 Months Ended
In Millions, unless otherwise specified	Mar. 31, 2014	Mar. 31, 2015
Gilbert AZ [Member]
Significant Acquisitions and Disposals [Line Items]
Amortization of the related lease intangible asset	$1
Straight line rent receivables write-off	1.1
Real estate investment		$14.10

Recovered_Sheet2

Real Estate and Lending Activities - Summary of Loans (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Loans [Line Items]
Loans, Balance	$1,039,548	$970,761
Mortgage loans [Member]
Loans [Line Items]
Loans, Balance	437,591	397,594
Working capital and other loans [Member]
Loans [Line Items]
Loans, Balance	46,566	48,031
Acquisition loans [Member]
Loans [Line Items]
Loans, Balance	$555,391	$525,136

Recovered_Sheet3

Real Estate and Lending Activities - Loans - Additional Information (Detail) (USD $)	0 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Mar. 01, 2012	Mar. 31, 2015	Mar. 01, 2012
Significant Acquisitions and Disposals [Line Items]
Amount of convertible note converted into equity interest	$1.70
Convertible note	5		5
Percentage of equity shares from convertible debt	9.90%	15.10%
Remaining convertible debt after conversion of part of debt		3.3
Ernest Transaction and Other Acquisitions [Member]
Significant Acquisitions and Disposals [Line Items]
Existing mortgage loans		102.5
MEDIAN Transaction [Member]
Significant Acquisitions and Disposals [Line Items]
Existing mortgage loans		$442.40

Recovered_Sheet4

Real Estate and Lending Activities - Concentrations of Credit Risk - Additional Information (Detail) (USD $)	3 Months Ended		12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Significant Acquisitions and Disposals [Line Items]
Revenues	$95,961	$73,089
European [Member]
Significant Acquisitions and Disposals [Line Items]
Revenues	$16,300	$5,500
Customer Concentration Risk [Member] | Prime Health Care Services [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of total assets leased	15.20%		12.60%
Percentage of total assets loaned	8.30%		7.40%
Customer Concentration Risk [Member] | Ernest Health, Inc [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of total assets leased	7.90%		7.70%
Percentage of total assets loaned	5.30%		5.30%
Assets, Total [Member]
Significant Acquisitions and Disposals [Line Items]
Number of investment in property	0
Maximum percentage of entity's total assets invested on single property	4.00%
Assets, Total [Member] | Customer Concentration Risk [Member] | MEDIAN Transaction [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of entity revenue from affiliates	11.60%		11.30%
Assets, Total [Member] | Geographic Concentration Risk [Member] | California [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of entity revenue from affiliates	14.30%		14.60%
Assets, Total [Member] | Geographic Concentration Risk [Member] | Texas [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of entity revenue from affiliates	20.50%		20.20%
Assets, Total [Member] | Geographic Concentration Risk [Member] | United States
Significant Acquisitions and Disposals [Line Items]
Percentage of entity revenue from affiliates	80.00%
Assets, Total [Member] | Geographic Concentration Risk [Member] | European [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of entity revenue from affiliates	80.00%		20.00%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Prime Health Care Services [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of entity revenue from affiliates	25.00%	29.10%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | MEDIAN Transaction [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of entity revenue from affiliates	9.50%
Sales Revenue, Net [Member] | Customer Concentration Risk [Member] | Ernest Health, Inc [Member]
Significant Acquisitions and Disposals [Line Items]
Percentage of entity revenue from affiliates	15.30%	19.60%

Debt_Summary_of_Debt_Detail

Debt - Summary of Debt (Detail) (USD $)	3 Months Ended	12 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Debt Instrument [Line Items]
Principal amount	$1,879,886
Debt	1,882,319	2,201,654
2011 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	6.88%	6.88%
Debt	450,000	450,000
Revolving credit facility [Member]
Debt Instrument [Line Items]
Interest rate	Variable	Variable
Debt	301,655	593,490
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Interest rate	Various	Various
Debt	125,000	125,000
2012 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	6.38%	6.38%
Principal amount	350,000	350,000
Unamortized premium	2,433	2,522
Debt	352,433	352,522
2013 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	5.75%	5.75%
Debt	214,620	241,960
2014 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Senior unsecured notes, interest rate	5.50%	5.50%
Debt	300,000	300,000
Term Loans [Member]
Debt Instrument [Line Items]
Interest rate	Various	Various
Debt	$138,611	$138,682

Debt_Principal_Payments_Due_fo

Debt - Principal Payments Due for Debt (Detail) (USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
Debt Disclosure [Abstract]
2015	$211
2016	125,299
2017	320
2018	314,436
2019	125,000
Thereafter	1,314,620
Total	$1,879,886

Debt_Interest_Rate_Swap_Additi

Debt - Interest Rate Swap - Additional Information (Detail) (USD $)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Jun. 30, 2010	Dec. 31, 2014	Oct. 31, 2011
Interest Rate Contract [Member]
Debt Instrument [Line Items]
Fair value of the interest rate swaps	5,500,000			$6,000,000
Interest Rate Contract One [Member]
Debt Instrument [Line Items]
Interest rate of interest rate derivative instrument	5.51%
Maturity date of interest rate swap	Jul-16
Interest Rate Contract Two [Member]
Debt Instrument [Line Items]
Maturity date of interest rate swap	Oct-16
Interest rate swap, amount fixed					60,000,000
Interest rate of derivative instrument	5.68%
Interest Rate Swap [Member]
Debt Instrument [Line Items]
Hedge ineffectiveness and income statement effect in period	0	0
Other assets, collateral	2,800,000			3,300,000
2006 Senior Unsecured Notes [Member]
Debt Instrument [Line Items]
Portion of debt instrument face amount			$65,000,000

Debt_Covenants_Additional_Info

Debt - Covenants - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2015
Debt Disclosure [Abstract]
Percentage of dividends which could be paid from adjusted operating funds	95.00%
Percentage of dividends which could be paid from operation funds	95.00%
Maximum percentage of total unencumbered assets	150.00%

Common_StockPartners_Capital_A

Common Stock/Partner's Capital - Additional Information (Detail) (USD $)	3 Months Ended		0 Months Ended		1 Months Ended
	Mar. 31, 2015	Mar. 31, 2014	Jan. 14, 2015	Mar. 11, 2014	Jan. 31, 2014	Dec. 31, 2014
Class of Stock [Line Items]
Common stock, shares issued	207,731,000					172,743,000
Proceeds from sale of common shares/units, net of offering costs	$479,966,000	$112,583,000
MPT Operating Partnership, L.P. [Member]
Class of Stock [Line Items]
Proceeds from sale of common shares/units, net of offering costs	479,966,000	112,583,000
Ownership interest in equity	99.80%
Number of units sold	34,500,000	8,600,000
Number of other partners	3
Employee [Member]
Class of Stock [Line Items]
Number of partners shared remaining ownership percentage	2
Director [Member]
Class of Stock [Line Items]
Number of partners shared remaining ownership percentage	1
Public Offering [Member]
Class of Stock [Line Items]
Common stock, shares issued			34,500,000	7,700,000
Time granted to underwriters to purchase shares	30 days
Additional shares purchased by underwriters			4,500,000	1,200,000
Proceeds from sale of common shares/units, net of offering costs			480,000,000	100,200,000
Net proceeds from additional issuance of shares				16,000,000
Market Equity Offering Program [Member]
Class of Stock [Line Items]
Common stock, shares issued	0	900,000
Proceeds from sale of common shares/units, net of offering costs		12,300,000
Sales commission percentage					1.25%
Market Equity Offering Program [Member] | IPO [Member]
Class of Stock [Line Items]
Public offering price for common stock per share		$13.21
Market Equity Offering Program [Member] | Maximum [Member]
Class of Stock [Line Items]
Number of shares can be sold out					250,000,000

Stock_Awards_Additional_Inform

Stock Awards - Additional Information (Detail)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Time-Based Awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, multi-year performance-based awards	217,177	338,484
Stock awards vesting period in years	3 years
Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, multi-year performance-based awards	176,046	317,254
Stock awards vesting period in years	3 years
Multi-year performance-based awards [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation, multi-year performance-based awards	505,050	500,000
Stock awards vesting period in years	3 years
Equity Incentive Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Reserved shares of common stock for awards under the Equity Incentive Plan	7,643,651
Common stock remaining for future stock awards transferred to the equity incentive plan	5,417,878

Fair_Value_of_Financial_Instru2

Fair Value of Financial Instruments - Summary of Fair Value Information of Financial Instruments (Detail) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Fair Value Disclosures [Abstract]
Interest and rent receivables, Book value	$40,464	$41,137
Loans, Book value	837,098	773,311
Debt, net Book value	-1,882,319	-2,201,654
Interest and rent receivables, Fair value	40,324	41,005
Loans, Fair value	867,523	803,824
Debt, net Fair value	($1,981,158)	($2,285,727)

Fair_Value_of_Financial_Instru3

Fair Value of Financial Instruments - Equity Interest in Ernest and Related Loans Measured at Fair Value on Recurring Basis (Detail) (USD $)	Mar. 31, 2015
In Thousands, unless otherwise specified
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	$205,750
Cost	205,750
Fair Value Measurements, Recurring [Member] | Acquisition loans [Member] | Other loans [Member]
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	102,450
Cost	102,450
Fair Value Measurements, Recurring [Member] | Equity investments [Member] | Other assets [Member]
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	3,300
Cost	3,300
Fair Value Measurements, Recurring [Member] | Mortgage loans [Member] | Mortgage loans [Member]
Financial Instruments Measured At Fair Value On Recurring Basis [Line Items]
Fair Value	100,000
Cost	$100,000

Fair_Value_of_Financial_Instru4

Fair Value of Financial Instruments - Additional information (Detail)	3 Months Ended
	Mar. 31, 2015
Fair Value Disclosures [Abstract]
Adjustment for marketability discount	40.00%

Fair_Value_of_Financial_Instru5

Fair Value of Financial Instruments - Summary Showing Sensitivity Analysis by Using Basis Point Variations (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015
+100 basis points [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Increase (Decrease) In Fair Value of Financial Instruments	($443)
- 100 basis points [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Estimated Increase (Decrease) In Fair Value of Financial Instruments	$443

Earnings_Per_Share_Calculation

Earnings Per Share - Calculation of Earnings Per Share (Detail) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	$35,976	$7,309
Non-controlling interests' share in continuing operations	-79	-66
Participating securities' share in earnings	-266	-209
Income from continuing operations, less participating securities' share in earnings	35,631	7,034
Income (loss) from discontinued operations		-2
Net income, less participating securities' share in earnings	35,631	7,032
Basic weighted-average common shares	202,958	163,973
Dilutive potential common shares	657	576
Dilutive weighted-average common shares	203,615	164,549
MPT Operating Partnership, L.P. [Member]
Earnings Per Share, Basic, by Common Class, Including Two Class Method [Line Items]
Income from continuing operations	35,976	7,309
Non-controlling interests' share in continuing operations	-79	-66
Participating securities' share in earnings	-266	-209
Income from continuing operations, less participating securities' share in earnings	35,631	7,034
Income (loss) from discontinued operations		-2
Net income, less participating securities' share in earnings	$35,631	$7,032
Basic weighted-average common shares	202,958	163,973
Dilutive potential common shares	657	576
Dilutive weighted-average common shares	203,615	164,549

Subsequent_Events_Additional_I

Subsequent Events - Additional Information (Detail) (Subsequent Event [Member], Adeptus Health [Member], USD $)	0 Months Ended
In Millions, unless otherwise specified	Apr. 30, 2015
	Leases
Subsequent Event [Member] | Adeptus Health [Member]
Subsequent Event [Line Items]
Aggregate commitment amount	$250
Lease agreement term	15 years
Term of lease extensions, years	5 years
Number of lease extension options	3
Percentage of increase in annual rent	2.00%